In B-cell lymphoma, mutant CREBBP proteins are deficient in acetylating BCL6 and p53, leading to the constitutive activation of BCL6 and decreased p53 tumor suppressor activity [46]. Here, BCL6 is linked to B-cell non-Hodgkin lymphoma.